Expert Reflects on Immunotherapy’s Milestone Impact in NSCLC, and Questions That Still Remain – Targeted Oncology
Targeted Oncology |
Expert Reflects on Immunotherapy's Milestone Impact in NSCLC, and Questions That Still Remain
Targeted Oncology Immunotherapy has made a significant impact in the field of non–small cell lung cancer (NSCLC). However, as more research unravels, investigators are unsure which set of combinations will have the most positive effect on their patients with advanced … |
